KTTA — Pasithea Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Pasithea Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.17 | -11.7 | -15.5 | -13.9 | -20.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1.11 | -2.81 | -0.14 | 0.852 | 4.87 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.111 | 0.845 | 1.57 | -1.52 | -0.319 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -3.17 | -13.7 | -13.4 | -13.9 | -15.2 |
| Capital Expenditures | -0.021 | -0.107 | -0.034 | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -2.82 | 0.433 | 0 | 0.011 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.021 | -2.93 | 0.399 | 0 | 0.011 |
| Financing Cash Flow Items | 20.6 | 0 | 0 | 0 | -0.448 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 55.9 | -3.21 | -3.73 | 4.52 | 63.5 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 52.7 | -19.8 | -16.8 | -9.41 | 48.3 |